Matrix metalloproteinase-13 expression is associated with bone marrow microinvolvement and prognosis in non-small cell lung cancer

Lung Cancer

Volumn 52, Issue 3, 2006, Pages 349-357

  Hsu, Chung Ping ^a,b   Shen, Gwan Han ^a   Ko, Jiunn Liang ^c  

^a TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Bone marrow microinvolvement; Matrix metalloproteinase; Non small cell lung cancer

Indexed keywords

COLLAGENASE 3; MATRILYSIN; STROMELYSIN; TUMOR MARKER;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BONE MARROW; BONE MARROW BIOPSY; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; CELL TYPE; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC KIT; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; PROTEIN AGGREGATION; PROTEIN EXPRESSION; SEX DIFFERENCE; SURVIVAL RATE; TUMOR CELL; TUMOR DIFFERENTIATION; TUMOR GROWTH; UNIVARIATE ANALYSIS; UPREGULATION;

EID: 33646370733     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2006.01.011     Document Type: Article

References (33)

1. Stetler-Stevenson W.G., Hewitt R., and Corcoran M. Matrix metalloproteinases and tumor invasion: from correlation and causality to the clinic. Semin Biol 7 (1996) 147-154
2. Nelson A.R., Fingleton B., Rothenberg M.L., and Matrisian L.M. Matrix metalloproteinases, biologic activity and clinical implications. J Clin Oncol 18 (2000) 1135-1149
3. Hidalgo M., and Eckhardt G.S. Development of matrix metalloproteinase inhibitors in cancer therapy. J Natl Cancer Inst 93 (2001) 178-193
4. Chambers A.F., and Matrisian L.M. Changing views of the role of matrix metalloproteinases in metastasis. J Natl Cancer Inst 89 (1997) 1260-1270
5. Cox G., Steward W.P., and O'Byrne K.J. The plasmin cascade and matrix metalloproteinases in non-small cell lung cancer. Thorax 54 (1999) 169-179
6. Drummond A.H., Beckett P., Brown P.D., Bone E.A., Davidson A.H., Galloway W.A., et al. Preclinical and clinical studies of MMP inhibitors in cancer. Ann NY Acad Sci 878 (1999) 228-235
7. Hsu C.P., Chen C.Y., Kwang P.C., Miao J., and Shai S.E. Bone-marrow microinvolvement in non-small cell lung cancer is not a reliable indicator of tumour recurrence and prognosis. Eur J Surg Oncol 26 (2000) 691-695
8. Hsu C.P., Shai S.E., Hsia J.Y., and Chen C.Y. Clinical significance of bone marrow microinvolvement in non-small cell lung carcinoma. Cancer 100 (2004) 794-800
9. In: Greene F.L., Page D.L., Fleming I.D., Fritz A.G., Balch C.M., Haller D.G., and Morrow M. (Eds). AJCC cancer staging handbook. 6th ed. (2002), Springer-Verlag Inc., New York 191-203
10. Berois N., Varangot M., Aizen B., Estrugo R., Zarantonelli L., Fernandez P., et al. Molecular detection of cancer cells in bone marrow and peripheral blood of patients with operable breast cancer. Comparison of CK19, MUC1 and CEA using RT-PCR. Eur J Cancer 36 (2000) 717-723
11. Dimmler A., Gerhards R., Betz C., Gunther K., Reingruber B., Horbach T., et al. Transcription of cytokeratins 8, 18, and 19 in bone marrow and limited expression of cytokeratins 7 and 20 by carcinoma cells: inherent limitations for Rt-Pcr in the detection of isolated tumor cells. Lab Invest 81 (2001) 1351-1361
12. Luzzi K.J., MacDonald I.C., Schmidt E.E., Kerkvliet N., Morris V.L., Chambers A.F., et al. Multistep nature of metastatic inefficiency: dormancy of solitary cells after successful extravasation and limited survival of early micrometastases. Am J Pathol 153 (1998) 865-873
13. Sienel W., Hellers J., Morresi-Hauf A., Lichtinghagen R., Mutschler W., Jochum M., et al. Prognostic impact of matrix metalloproteinase-9 in operable non-small cell lung cancer. Int J Cancer 103 (2003) 647-651
14. Passlick B., Sienel W., Seen-Hibler R., Wockel W., Thetter O., Mutschler W., et al. Overexpression of matrix metalloproteinase 2 predicts unfavorable outcome in early-stage non-small cell lung cancer. Clin Cancer Res 10 (2000) 3944-3948
15. Lin T.S., Chiou S.H., Wang L.S., Huang H.H., Chiang S.F., Shih A.Y., et al. Expression spectra of matrix metalloproteinase in metastatic non-small cell lung cancer. Oncol Rep 12 (2004) 717-723
16. Ishikawa S., Takenaka K., Yanagihara K., Miyahara R., Kawano Y., Otake Y., et al. Matrix metalloproteinase-2 status in stromal fibroblasts, not in tumor cells, is a significant prognostic factor in non-small-cell lung cancer. Clin Cancer Res 10 (2004) 6579-6585
17. Sasaki H., Yukiue H., Moiriyama S., Kobayashi Y., Nakashima Y., Kaji M., et al. Clinical significance of matrix metalloproteinase-7 and Ets-1 gene expression in patients with lung cancer. J Surg Res 101 (2001) 242-247
18. Monig S.P., Baldus S.E., Hennecken J.K., Spiecker D.B., Grass G., Schneider P.M., et al. Expression of MMP-2 is associated with progression and lymph node metastasis of gastric carcinoma. Histopathology 39 (2001) 597-602
19. Langenskiold M., Holmdahl L., Falk P., and Ivarsson M.L. Increased plasma MMP-2 protein expression in lymph node-positive patients with colorectal cancer. Int J Colorectal Dis 20 (2005) 245-252
20. Vlems F.A., Ruers T.J.M., Punt C.J.A., Wobbes T., and van Muijen G.N.P. Relevance of disseminated tumour cells in blood and bone marrow of patients with solid epithelial tumours in perspective. Eur J Surg Ocol 29 (2003) 289-302
21. Woelfle U., Cloos J., Sauter G., Riethdorf L., Jänicke F., van Diest P., et al. Molecular signature associated with bone marrow micrometastasis in human breast cancer. Cancer Res 63 (2003) 5679-5684
22. Jiao X., and Krasna M.J. Clinical significance of micrometastasis in lung and esophageal cancer: an new paradigm in thoracic oncology. Ann Thorac Surg 74 (2002) 278-284
23. Weitz J., Kienle P., Magener A., Koch M., Schrodel A., Willeke F., et al. Detection of disseminated colorectal cancer cells in lymph nodes, blood and bone marrow. Clin Cancer Res 5 (1999) 1830-1836
24. Ito H., Hatori M., Kinugasa Y., Irie T., Tachikawa T., and Nagumo M. Comparison of the expression profile of metastasis-associated genes between primary and circulating cancer cells in oral squamous cell carcinoma. Anticancer Res 23 (2003) 1425-1431
25. Pendas A.M., Balbin M., Llano E., Jimenez M.G., and Lopez-Otin C. Structure analysis and promoter characterization of the human collagenase-3 gene (MMP13). Genomics 40 (1997) 222-233
26. Johansson N., Saarialho-Kere U., Airola K., Herva R., Nissinen L., Westermarck J., et al. Collagenase-3 is expressed by hypertrophic chondrocytes, periosteal cells, and ostoblasts during human fetal bone development. Dev Dyn 208 (1997) 387-397
27. Wernicke D., Seyfert C., Hinzmann B., and Gromnic-Ihle E. Cloning of collagenase 3 from the synovial membrane and its expression in rheumatoid arthritis and osteoarthritis. J Rheumatol 23 (1996) 590-595
28. Woessner J.F. Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J 5 (1991) 2145-2154
29. Uria J.A., Balbin M., Lopez J.M., Alvarez J., Vizoso F., Takigawa M., et al. Collagenase-3 expression in chondrosarcoma cells and its regulation by basic fibroblast growth factor. Am J Pathol 153 (1998) 91-101
30. Mitchell P.G., Magna H.A., Reeves L.M., Lopresti-Morrow L.L., Yocum S.A., Rosner P.J., et al. Cloning, expression, and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage. J Clin Invest 97 (1996) 761-768
31. Balbin M., Pendas A.M., Uria J.A., Jimenez M.G., Freije J.P., and Lopez-Otin C. Expression and regulation of collagenase-3 (MMP-13) in human malignant tumors. APMIS 107 (1999) 45-53
32. Etoh T., Inoue H., Yoshikawa Y., Barnard G.F., Kitano S., and Mori M. Increased expression of collagenase-3 (MMP-13) and MT1-MMP in oesophageal cancer is related to cancer aggressiveness. Gut 47 (2000) 50-56
33. Morgia G., Falsaperla M., Malaponte G., Madonia M., Indelicato M., Travali S., et al. Matrix metalloproteinases as diagnostic (MMP-13) and prognostic (MMP-2, MMP-9) markers of prostate cancer. Urol Res 33 (2004) 44-50